1. Home
  2. ABUS vs DDI Comparison

ABUS vs DDI Comparison

Compare ABUS & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • DDI
  • Stock Information
  • Founded
  • ABUS N/A
  • DDI 2008
  • Country
  • ABUS United States
  • DDI South Korea
  • Employees
  • ABUS N/A
  • DDI N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • DDI EDP Services
  • Sector
  • ABUS Health Care
  • DDI Technology
  • Exchange
  • ABUS Nasdaq
  • DDI Nasdaq
  • Market Cap
  • ABUS 636.2M
  • DDI 493.6M
  • IPO Year
  • ABUS N/A
  • DDI 2021
  • Fundamental
  • Price
  • ABUS $3.06
  • DDI $9.72
  • Analyst Decision
  • ABUS Strong Buy
  • DDI Strong Buy
  • Analyst Count
  • ABUS 4
  • DDI 4
  • Target Price
  • ABUS $5.50
  • DDI $21.50
  • AVG Volume (30 Days)
  • ABUS 997.4K
  • DDI 42.6K
  • Earning Date
  • ABUS 05-01-2025
  • DDI 02-11-2025
  • Dividend Yield
  • ABUS N/A
  • DDI N/A
  • EPS Growth
  • ABUS N/A
  • DDI N/A
  • EPS
  • ABUS N/A
  • DDI 2.50
  • Revenue
  • ABUS $6,742,000.00
  • DDI $341,330,000.00
  • Revenue This Year
  • ABUS N/A
  • DDI $1.98
  • Revenue Next Year
  • ABUS N/A
  • DDI $2.43
  • P/E Ratio
  • ABUS N/A
  • DDI $3.78
  • Revenue Growth
  • ABUS N/A
  • DDI N/A
  • 52 Week Low
  • ABUS $2.30
  • DDI $8.56
  • 52 Week High
  • ABUS $4.72
  • DDI $18.21
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 34.37
  • DDI 44.14
  • Support Level
  • ABUS $3.32
  • DDI $9.06
  • Resistance Level
  • ABUS $3.55
  • DDI $10.03
  • Average True Range (ATR)
  • ABUS 0.17
  • DDI 0.33
  • MACD
  • ABUS -0.04
  • DDI -0.00
  • Stochastic Oscillator
  • ABUS 5.88
  • DDI 54.19

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.

Share on Social Networks: